Abou-Alfa Highlights Pending Approvals, Sequencing Concerns, and Future Directions in HCC
Published: Thursday, Apr 02, 2020
Ghassan K. Abou-Alfa, MD
The armamentarium in advanced hepatocellular carcinoma (HCC) has undergone rapid expansion in recent years following a significant lull in drug development, said Ghassan K. Abou-Alfa, MD.
... to read the full story